Skip to main content
. Author manuscript; available in PMC: 2023 Oct 1.
Published in final edited form as: J Invest Dermatol. 2022 Apr 4;142(10):2773–2782.e16. doi: 10.1016/j.jid.2022.03.017

Figure 2: AK- and SCC-associated biomarkers.

Figure 2:

a: Richness comparing matched (gray lines) HS vs. AK, and SCC. b: PCoA clustering of scaled data. Ellipses and density plots are described in Supplementary Materials and Methods, c and d: LDA score plot showing differentially abundant genera in HS vs. AK, and SCC (matched datasets). Scores ≥2 for HS vs. AK and ≥3 for HS vs. SCC (full datasets in Figure S4) were ranked by effect size, e: Abundances of C. acnes, f: S. aureus for matched HS vs. AK and SCC. g: C. acnes:S. aureus ratio in scaled dataset. P-values were calculated by paired (a, e, f) and unpaired (g) Wilcoxon test. For (g), p-values were FDR-corrected. P-value of mixed effects models: *<0.1, **<0.05, ***<0.01 (Table S7).